Home > Financial Ratios > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Core EBITDA Growth

    Back to All Ratios
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results

PROCTER & GAMBLE HEALTH Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Jun2024Jun2023Jun2022
   Core EBITDA Growth(%) 44.192.21-6.2522.156.34

What is the latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH ?

The latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH is 44.19 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar202644.19
Mar20252.21
Jun2024-6.25
Jun202322.15
Jun20226.34

How is Core EBITDA Growth of PROCTER & GAMBLE HEALTH Trending?

Years Core EBITDA Growth % Change
Mar2026 44.19
1,899.55
Mar2025 2.21
Positive
Jun2024 -6.25
Negative
Jun2023 22.15
249.37
Jun2022 6.34 -

Other Financial Ratios of PROCTER & GAMBLE HEALTH


Compare Core EBITDA Growth ratio of peers of PROCTER & GAMBLE HEALTH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH ₹9,003.2 Cr -1.4% -7% -13.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,597.0 Cr 1% -3.3% 13.1% Stock Analytics
DIVIS LABORATORIES ₹255,195.0 Cr 2.6% 10.8% 57.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,712.0 Cr 2.7% 0.3% 39.6% Stock Analytics
CIPLA ₹113,423.0 Cr 2.4% -1.1% -12.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,195.0 Cr 2.5% 0.8% -8.5% Stock Analytics


PROCTER & GAMBLE HEALTH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH

-1.4%

-7%

-13.2%

SENSEX

-1%

-4.9%

-11%


You may also like the below Video Courses